Effect of expanded hemodialysis on body composition and nutritional status
- Compared to HD, MCO-HD improved lean tissue mass (p=0.008), lean tissue index (p=0.013), skeletal muscle index (p=0.046), and serum creatinin (p=0.044)
This site is intended for Healthcare Professionals only. All products may not be available in all countries. Contact your local Baxter representative.
We deliver and support renal therapies across the continuum of care, including the innovative HDx.
TherapiesModern PD offers patients many choices. Are you ready to voice them?
Peritoneal Dialysis - combined with Remote Patient Management - offers the potential to improve renal patients' clinical outcomes and increase lifestyle flexibility.
Hemodialysis is the predominant therapy for end-stage kidney disease, and can be delivered through multiple therapy options.
Innovative Expanded Hemodialysis (HDx) therapy is the next evolution in hemodialysis treatment.
Learn more about Baxter’s key products for Renal Care – across the continuum of care.
Peritoneal Dialysis
Groundbreaking research and inspirational patient stories.
Explore the research enabling innovative Renal Care.
Patients’ journeys inspire our work and drive our commitment.
Access resources for Baxter’s broader Renal Care portfolio.
This site is intended for Healthcare Professionals only. All products may not be available in all countries. Contact your local Baxter representative.